Research project
HORIZON-HLTH-2022-DISEASE-06-two-stage
Therapeutic epigenetic enhancement of the innate immunity to effectively. Combat antimicrobial resistance [IN-ARMOR]
date_range
Duration: from 01 May 2023 to 30 April 2027
(48 months)
It has been granted under a regime of Competitive.
